eIF4A1 is a promising new therapeutic target in ER-negative breast cancer
Cell Death Differ
.
2015 Apr;22(4):524-5.
doi: 10.1038/cdd.2014.210.
Epub 2015 Jan 23.
Authors
M Stoneley
1
,
A E Willis
1
Affiliation
1
MRC Toxicology Unit, Hodgkin Building, Lancaster Road, Leicester LE1 9HN, UK.
PMID:
25613380
PMCID:
PMC4356343
DOI:
10.1038/cdd.2014.210
No abstract available
Publication types
Comment
MeSH terms
Breast Neoplasms / metabolism*
Breast Neoplasms / pathology*
Eukaryotic Initiation Factor-4A / metabolism*
Female
Humans
Protein Biosynthesis*
Substances
Eukaryotic Initiation Factor-4A
Grants and funding
MC_UP_A600_1023/MRC_/Medical Research Council/United Kingdom